Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Wetzler

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Journal of Psychosocial Oncology|January 15, 2015
Acceptability, feasibility, and efficacy of a supportive group intervention for caregivers of newly diagnosed leukemia patientsMegan E Pailler, Teresa M Johnson, Michael A Zevon, et al.
Leukemia Research Reports|November 8, 2014
Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemiaKristin K Deeb, Matthew T Smonskey, HanChun DeFedericis, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Leukemia & Lymphoma|December 1, 2012
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populationsJawad Francis, Avinash V Dharmadhikari, Sheila N J Sait, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid LeukemiaMonica R Muppidi, Scott Portwood, Elizabeth A Griffiths, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndromeRenuka V Iyer, Sheila N J Sait, Sei-Ichi Matsui, et al.
Leukemia Research|December 24, 2010
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemiaGeorge Deeb, Mary M Vaughan, Ian McInnis, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapseEunice S Wang, Sheila N J Sait, David Gold, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Leukemia Research|May 1, 2013
Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell functionMichael T Brady, Austin Miller, Sheila N Sait, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Journal of Psychosocial Oncology|January 15, 2015
Acceptability, feasibility, and efficacy of a supportive group intervention for caregivers of newly diagnosed leukemia patientsMegan E Pailler, Teresa M Johnson, Michael A Zevon, et al.
Leukemia Research Reports|November 8, 2014
Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemiaKristin K Deeb, Matthew T Smonskey, HanChun DeFedericis, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Leukemia & Lymphoma|December 1, 2012
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populationsJawad Francis, Avinash V Dharmadhikari, Sheila N J Sait, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid LeukemiaMonica R Muppidi, Scott Portwood, Elizabeth A Griffiths, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndromeRenuka V Iyer, Sheila N J Sait, Sei-Ichi Matsui, et al.
Leukemia Research|December 24, 2010
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemiaGeorge Deeb, Mary M Vaughan, Ian McInnis, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapseEunice S Wang, Sheila N J Sait, David Gold, et al.
British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.
Leukemia Research|May 1, 2013
Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell functionMichael T Brady, Austin Miller, Sheila N Sait, et al.
Pageof 12